Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Relationship between estrogen and schizophrenia.

A M Mortimer1

  • 1The University of Hull, Department of Psychiatry, Hertford Building, Cottingham Road, Hull HU6 7RX, UK. a.m.mortimer@hull.ac.uk

Expert Review of Neurotherapeutics
|December 26, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Update on the Royal College of Radiologists sponsored credential Mechanical Thrombectomy for Acute Ischaemic Stroke: thoughts about implementation in an under-resourced environment.

Clinical radiology·2023
Same author

Carryover effects on the clonal growth of the grass Holcus lanatus L.

The New phytologist·2021
Same author

Electroencephalographic (EEG) features of encephalopathy in the setting of Covid-19: A case series.

Clinical neurophysiology practice·2020
Same author

Anaesthetic preferences for endovascular stroke thrombectomy.

Anaesthesia·2020
Same author

Spinal dural arteriovenous fistula: delay to radiological diagnosis and sources of radiological error.

Clinical radiology·2018
Same author

DIVERGENCE AND GENETIC STRUCTURE IN ADJACENT GRASS POPULATIONS. I. QUANTITATIVE GENETICS.

Evolution; international journal of organic evolution·2017
Same journal

An overview of the safety and efficacy of sphenopalatine ganglion stimulation for the treatment of chronic cluster headache.

Expert review of neurotherapeutics·2026
Same journal

Multiomics and proteomic insights into Alzheimer's disease biology in Down syndrome.

Expert review of neurotherapeutics·2026
Same journal

Remote deep brain stimulation programming in childhood dystonia: opportunities, challenges, and future directions.

Expert review of neurotherapeutics·2026
Same journal

The differential diagnosis of astrocytic neoplasms and its impact on treatment and prognosis.

Expert review of neurotherapeutics·2026
Same journal

Corticosteroids in withdrawal therapy following medication-overuse headache: a systematic review.

Expert review of neurotherapeutics·2026
Same journal

Clinical efficacy of lacosamide in neuropathic pain: a systematic review of randomized controlled trials.

Expert review of neurotherapeutics·2026
See all related articles

Female schizophrenia patients may have lower estrogen levels, potentially impacting treatment. Estrogen

Area of Science:

  • Neuroscience
  • Endocrinology
  • Psychiatry

Background:

  • Female schizophrenia patients may exhibit estrogenic function deficits.
  • Antipsychotic drugs can lower estrogen levels via prolactin induction.
  • Estrogen's neuroprotective and neurotransmitter roles are under investigation.

Purpose of the Study:

  • To evaluate estrogen's efficacy as an adjunctive therapy for schizophrenia in females.
  • To assess the potential benefits and risks of estrogen in schizophrenia treatment.

Main Methods:

  • Review of historical and circumstantial evidence.
  • Analysis of existing studies, including limited double-blind, randomized controlled trials.
  • Consideration of risks associated with hormone replacement therapy.

Related Experiment Videos

Main Results:

  • Most studies on estrogen as an adjunct therapy lack rigorous design.
  • Only two small double-blind trials showed positive results; one long-term study was negative.
  • Concerns exist regarding the risks of long-term hormone replacement therapy.

Conclusions:

  • Estrogen's role in schizophrenia treatment remains uncertain due to mixed evidence and safety concerns.
  • Specific estrogen receptor modulators may offer a safer alternative, but their utility depends on estrogen's direct relevance to schizophrenia pathophysiology.
  • Further research is needed to clarify estrogen's specific antipsychotic or adjuvant mechanisms.